2002, Drug Development and Drug Pricing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2002

Drug Development

Drug Pricing

Panel urges FDA to remove warnings on hormonal menopause therapy

BioPharma Dive

JULY 18, 2025

The study was stopped early in 2002 after researchers observed an increased risk of breast cancer and heart disease. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy.

Labelling

Labelling Drug Pricing Vaccines Medical Schools

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

SEPTEMBER 14, 2023

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

Drug Development

Drug Development Drug Pricing Communication

Pharmacist Digest

Panel urges FDA to remove warnings on hormonal menopause therapy

Achieving scale up success under economic uncertainty

Stay Connected